PL1696947T3 - Zastosowanie erytropoetyny w leczeniu zaburzeń dystrybucji żelaza w przewlekłych chorobach zapalnych jelit - Google Patents
Zastosowanie erytropoetyny w leczeniu zaburzeń dystrybucji żelaza w przewlekłych chorobach zapalnych jelitInfo
- Publication number
- PL1696947T3 PL1696947T3 PL04803748T PL04803748T PL1696947T3 PL 1696947 T3 PL1696947 T3 PL 1696947T3 PL 04803748 T PL04803748 T PL 04803748T PL 04803748 T PL04803748 T PL 04803748T PL 1696947 T3 PL1696947 T3 PL 1696947T3
- Authority
- PL
- Poland
- Prior art keywords
- erythropoietin
- disturbances
- treatment
- chronic inflammatory
- intestinal diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03104832 | 2003-12-19 | ||
PCT/EP2004/014105 WO2005058347A1 (en) | 2003-12-19 | 2004-12-10 | Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases |
EP04803748.5A EP1696947B1 (en) | 2003-12-19 | 2004-12-10 | Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1696947T3 true PL1696947T3 (pl) | 2014-08-29 |
Family
ID=34684610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04803748T PL1696947T3 (pl) | 2003-12-19 | 2004-12-10 | Zastosowanie erytropoetyny w leczeniu zaburzeń dystrybucji żelaza w przewlekłych chorobach zapalnych jelit |
Country Status (10)
Country | Link |
---|---|
US (1) | US7459429B2 (pl) |
EP (1) | EP1696947B1 (pl) |
JP (1) | JP2007514673A (pl) |
CN (1) | CN1901934B (pl) |
CA (1) | CA2549486C (pl) |
DK (1) | DK1696947T3 (pl) |
ES (1) | ES2460671T3 (pl) |
PL (1) | PL1696947T3 (pl) |
SI (1) | SI1696947T1 (pl) |
WO (1) | WO2005058347A1 (pl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070072795A1 (en) * | 2005-09-28 | 2007-03-29 | Anton Haselbeck | Treatment of neurodegenerative disorders |
US8946155B2 (en) | 2006-02-03 | 2015-02-03 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
US10221228B2 (en) | 2006-02-03 | 2019-03-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US20140113860A1 (en) | 2006-02-03 | 2014-04-24 | Prolor Biotech Ltd. | Long-acting polypeptides and methods of producing and administering same |
US7553940B2 (en) | 2006-02-03 | 2009-06-30 | Modigene Inc | Long-acting EPO polypeptides and derivatives thereof and methods thereof |
US9458444B2 (en) | 2006-02-03 | 2016-10-04 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
US8450269B2 (en) | 2006-02-03 | 2013-05-28 | Prolor Biotech Ltd. | Long-acting growth hormone and methods of producing same |
US8048848B2 (en) | 2006-02-03 | 2011-11-01 | Prolor Biotech Ltd. | Long-acting interferons and derivatives thereof and methods thereof |
US8048849B2 (en) | 2006-02-03 | 2011-11-01 | Modigene, Inc. | Long-acting polypeptides and methods of producing same |
US8304386B2 (en) | 2006-02-03 | 2012-11-06 | Prolor Biotech, Inc. | Long-acting growth hormone and methods of producing same |
US10351615B2 (en) | 2006-02-03 | 2019-07-16 | Opko Biologics Ltd. | Methods of treatment with long-acting growth hormone |
US8759292B2 (en) | 2006-02-03 | 2014-06-24 | Prolor Biotech, Llc | Long-acting coagulation factors and methods of producing same |
US8476234B2 (en) * | 2006-02-03 | 2013-07-02 | Prolor Biotech Inc. | Long-acting coagulation factors and methods of producing same |
US20150038413A1 (en) | 2006-02-03 | 2015-02-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US9663778B2 (en) | 2009-07-09 | 2017-05-30 | OPKO Biologies Ltd. | Long-acting coagulation factors and methods of producing same |
MY167814A (en) | 2012-04-19 | 2018-09-26 | Opko Biologics Ltd | Long-acting oxyntomodulin variants and methods of producing same |
CA2891393A1 (en) | 2012-11-20 | 2014-05-30 | Opko Biologics Ltd. | Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides |
US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
CN108289851B (zh) | 2015-06-19 | 2021-06-01 | Opko生物科学有限公司 | 长效凝固因子及其产生方法 |
RU2740060C1 (ru) * | 2020-02-14 | 2020-12-31 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Южно-Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ЮУГМУ Минздрава России) | Лекарственная форма для лечения и профилактики язвенного колита, содержащая пэгилированную липосомальную форму эритропоэтина в форме суппозиториев, обладающая противовоспалительным и иммуномодулирующим действием |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
FR2646438B1 (fr) | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
DE3924705A1 (de) | 1989-07-26 | 1991-01-31 | Boehringer Mannheim Gmbh | Heterobifunktionelle verbindungen |
ATE139574T1 (de) | 1989-11-06 | 1996-07-15 | Cell Genesys Inc | Herstellung von proteinen mittels homologer rekombination |
US5272071A (en) | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
US5324650A (en) | 1990-03-20 | 1994-06-28 | E. I. Du Pont De Nemours And Company | Situ process for production of conjugates |
US6565841B1 (en) | 1991-03-15 | 2003-05-20 | Amgen, Inc. | Pulmonary administration of granulocyte colony stimulating factor |
WO1992016555A1 (en) | 1991-03-18 | 1992-10-01 | Enzon, Inc. | Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
NZ244778A (en) | 1991-10-21 | 1994-03-25 | Ortho Pharma Corp | Peg imidates and protein derivatives thereof |
NZ245015A (en) | 1991-11-05 | 1995-12-21 | Transkaryotic Therapies Inc | Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production |
US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
US5968502A (en) | 1991-11-05 | 1999-10-19 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
ZA933926B (en) | 1992-06-17 | 1994-01-03 | Amgen Inc | Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules |
CA2101361A1 (en) | 1992-08-27 | 1994-02-28 | Robert A. Snow | Low diol polyalkylene oxide biologically active proteinaceous substances |
NZ250375A (en) | 1992-12-09 | 1995-07-26 | Ortho Pharma Corp | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives |
US5681811A (en) | 1993-05-10 | 1997-10-28 | Protein Delivery, Inc. | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same |
US5359030A (en) | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
WO1994028024A1 (en) | 1993-06-01 | 1994-12-08 | Enzon, Inc. | Carbohydrate-modified polymer conjugates with erythropoietic activity |
US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
ATE200030T1 (de) | 1997-01-29 | 2001-04-15 | Polymasc Pharmaceuticals Plc | Pegylationsverfahren |
ATE222118T1 (de) | 1997-03-18 | 2002-08-15 | Roche Diagnostics Gmbh | Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate |
JO2291B1 (en) * | 1999-07-02 | 2005-09-12 | اف . هوفمان لاروش ايه جي | Erythropoietin derivatives |
CZ299516B6 (cs) | 1999-07-02 | 2008-08-20 | F. Hoffmann-La Roche Ag | Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem |
WO2001087329A1 (en) | 2000-05-15 | 2001-11-22 | F. Hoffmann-La Roche Ag | Liquid pharmaceutical composition containing an erythropoietin derivate |
ES2297011T3 (es) | 2001-09-14 | 2008-05-01 | F. Hoffmann-La Roche Ag | Diagnostico diferencial de los trastornos del metabolismo del hierro por medio de tres parametros independientes y recomendaciones para el tratamiento de estos trastornos del metabolismo del hierro. |
US7459435B2 (en) * | 2002-08-29 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
US7459436B2 (en) * | 2002-11-22 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
WO2004091495A2 (en) * | 2003-04-09 | 2004-10-28 | University Of Utah Research Foundation | Compositions and methods related to production of erythropoietin |
-
2004
- 2004-12-10 EP EP04803748.5A patent/EP1696947B1/en active Active
- 2004-12-10 ES ES04803748.5T patent/ES2460671T3/es active Active
- 2004-12-10 PL PL04803748T patent/PL1696947T3/pl unknown
- 2004-12-10 SI SI200432148T patent/SI1696947T1/sl unknown
- 2004-12-10 WO PCT/EP2004/014105 patent/WO2005058347A1/en active Application Filing
- 2004-12-10 JP JP2006544291A patent/JP2007514673A/ja active Pending
- 2004-12-10 CN CN200480039809XA patent/CN1901934B/zh active Active
- 2004-12-10 DK DK04803748.5T patent/DK1696947T3/en active
- 2004-12-10 CA CA2549486A patent/CA2549486C/en active Active
- 2004-12-16 US US11/013,560 patent/US7459429B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
SI1696947T1 (sl) | 2014-05-30 |
CA2549486C (en) | 2015-04-14 |
ES2460671T3 (es) | 2014-05-14 |
EP1696947A1 (en) | 2006-09-06 |
CN1901934B (zh) | 2013-09-11 |
EP1696947B1 (en) | 2014-02-26 |
JP2007514673A (ja) | 2007-06-07 |
WO2005058347A1 (en) | 2005-06-30 |
DK1696947T3 (en) | 2014-03-17 |
US20050181986A1 (en) | 2005-08-18 |
US7459429B2 (en) | 2008-12-02 |
CN1901934A (zh) | 2007-01-24 |
CA2549486A1 (en) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1696947T3 (pl) | Zastosowanie erytropoetyny w leczeniu zaburzeń dystrybucji żelaza w przewlekłych chorobach zapalnych jelit | |
ZA200804742B (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
IL191637A0 (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
HK1088234A1 (en) | Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders | |
IL189578A0 (en) | Pyridine derivatives and their use in the treatment of psychotic disorders | |
IL175529A0 (en) | Methods and compositions for the treatment of metabolic disorders | |
EP1957462A4 (en) | NEW 2-AMINO-HETEROCYCLES USEFUL FOR THE TREATMENT OF ABETA-RELATED DISEASES | |
IL180759A0 (en) | Indazoles useful in treating cardiovascular diseases | |
IL175055A0 (en) | Combinations useful for the treatment of neuronal disorders | |
PL2275107T3 (pl) | Kombinacje do leczenia chorób związanych z proliferacją komórek | |
EP1490044A4 (en) | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMABLE COMPONENTS | |
IL181706A0 (en) | The treatment of inflammatory disorders and pain | |
ME01219B (me) | Alfa-aminoamid derivati korisni u liječenju bolesti zavisnosti | |
EP1744740A4 (en) | PHENOXYALKYCARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
IL175610A0 (en) | Methods and reagents for the treatment of inflammatory disorders | |
AU2003228819A8 (en) | Combinations for the treatment of inflammatory skin disorders | |
IL190969A0 (en) | Pyrazoles useful in the treatment of inflammation | |
EP1805210A4 (en) | NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE | |
EP1877801A4 (en) | ANALYSIS AND THERAPY OF COPPER REGULATION | |
IL173068A0 (en) | Acute inflammatory condition treatment | |
EP1997487A4 (en) | PRODUCT USED IN THE PREVENTION AND TREATMENT OF CARDIAC DISEASES, CANCER AND INFLAMMATORY DISEASES | |
EP1646381A4 (en) | COMBINED THERAPY FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES | |
GB0526394D0 (en) | Treatment of inflammatory diseases | |
GB0301395D0 (en) | Inflammatory disorder treatment | |
GB0428170D0 (en) | Mono and Combination Therapy |